About Hôpital Européen Georges Pompidou Service de Nephrologie
The Hôpital Européen Georges-Pompidou is a French hospital located in Paris. The HEGP is under the aegis of the Assistance publique - Hôpitaux de Paris. Opened in 2001, the HEGP is the last-born Parisian hospital resulting from the merger of three older hospitals of the 15th district.
Clinical Trials at Hôpital Européen Georges Pompidou Service de Nephrologie
During the past decade, Hôpital Européen Georges Pompidou Service de Nephrologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Européen Georges Pompidou Service de Nephrologie"
#1 collaborator was "Genzyme, a Sanofi Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Hôpital Européen Georges Pompidou Service de Nephrologie
According to Clinical.Site data, the most researched conditions in "Hôpital Européen Georges Pompidou Service de Nephrologie" are
"Chronic Renal Failure" (1 trials), "Influenza, Human" (1 trials) and "Renal Anemia of Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Hôpital Européen Georges Pompidou Service de Nephrologie" in a lesser frequency.
Clinical Trials Intervention Types at Hôpital Européen Georges Pompidou Service de Nephrologie
Most popular intervention types in "Hôpital Européen Georges Pompidou Service de Nephrologie" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Methoxy Polyethylene Glycol-Epoetin Beta" (1 trials), "Placebo" (1 trials), "Sevelamer carbonate" (1 trials), "oseltamivir" (1 trials) and "placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hôpital Européen Georges Pompidou Service de Nephrologie
The vast majority of trials in "Hôpital Européen Georges Pompidou Service de Nephrologie" are
3 trials for "All" genders.
Clinical Trials Status at Hôpital Européen Georges Pompidou Service de Nephrologie
Currently, there are NaN active trials in "Hôpital Européen Georges Pompidou Service de Nephrologie".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Hôpital Européen Georges Pompidou Service de Nephrologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hôpital Européen Georges Pompidou Service de Nephrologie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".